Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (15)

2024

  1. Antimicrobial Agent Use for Urinary Tract Infection in Long-Term Care Facilities in Spain: Results from a Retrospective Analytical Cohort Analysis

    Antibiotics, Vol. 13, Núm. 2

  2. Cross-cultural adaptation, reliability and validity of the Spanish version of the long-term quality of life questionnaire

    Frontiers in Oncology, Vol. 14

2022

  1. An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

    Pharmacopsychiatry, Vol. 55, Núm. 2, pp. 73-86

  2. Erratum: Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels (Pharmacopsychiatry (2022) 55 2 (73-86))

    Pharmacopsychiatry

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Increasing SARS-CoV-2 RT-qPCR testing capacity by sample pooling

    International Journal of Infectious Diseases, Vol. 103, pp. 19-22

2020

  1. Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples

    International Journal of Infectious Diseases, Vol. 97, pp. 66-68

  2. Sensitivity of different RT-qPCR solutions for SARS-CoV-2 detection

    International Journal of Infectious Diseases, Vol. 99, pp. 190-192

2019

  1. Editor’s Choice– Impact of identifying precipitating factors on 30-day mortality in acute heart failure patients

    European Heart Journal: Acute Cardiovascular Care, Vol. 8, Núm. 7, pp. 667-680

  2. Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count

    Journal of Microbiology, Immunology and Infection, Vol. 52, Núm. 4, pp. 667-671

2016

  1. MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression

    PLoS ONE, Vol. 11, Núm. 5

2011

  1. Users perception of risk and benefits of mood modifying drugs

    Current Clinical Pharmacology, Vol. 6, Núm. 2, pp. 108-114

2010

  1. The dopamine transporter is differentially regulated after dopaminergic lesion

    Neurobiology of Disease, Vol. 40, Núm. 3, pp. 518-530

2009

  1. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease

    Neurobiology of Disease, Vol. 36, Núm. 3, pp. 494-508

2001

  1. Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome

    Environmental Health Perspectives, Vol. 109, Núm. 4, pp. 369-375